We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Watson, GSK Reach Settlement Over Wellbutrin XL Patent Litigation
Watson, GSK Reach Settlement Over Wellbutrin XL Patent Litigation
February 20, 2007
Watson Pharmaceuticals has agreed to license its bupropion hydrochloride absorption method patent for $35 million as part of a settlement to resolve patent litigation regarding GlaxoSmithKline’s (GSK) Wellbutrin XL.